top of page
  • Writer's picturegestam

"In silico medicine is now in the ECDC regulation!"

This is fantastic news for in silico medicine!

Φανταστικά νέα για την In Silico Ιατρική!

Ιn silico medicine is incorporated into the scope of the Εuropean Centre for Disease Prevention and Control (ECDC)

H Ιn Silico Iατρική ενσωματώνεται στις μεθόδους και στα εργαλεία του Ευρωπαϊκού Κέντρου Πρόληψης και Ελέγχου Νόσων (ECDC)!

Τhis is a source of joy for the In Silico Oncology and In Silico Medicine Group, ICCS, SECE, National Technical University of Athens ( ), due to its pivotal contribution to the emergence, the shaping and the advancement of this exciting and highly promising new domain! See (section History)

Η εξέλιξη αυτή είναι πηγή ιδιαίτερης χαράς για την Eρευνητική Ομάδα για την In Silico Ογκολογία και την In Silico Ιατρική των ΕΠΙΣΕΥ-ΣΗΜΜΥ-Εθνικού Μετσοβίου Πολυτεχνείου ( ), λόγω της θεμελιώδους συμβολής της στη γένεση, στη διαμόρφωση και στην εξέλιξη αυτού του συναρπαστικού και πολλά υποσχόμενου νέου πεδίου! Δες (κεφάλαιο Ηistory)


"The three amendments suggested by Avicenna to MEP Radan Kanev (EPP, BG) for the European Centre for Disease Prevention and Control Regulation (ECDC) were adopted by the European Parliament on 14 September 2021 during the vote in plenary."

"The adopted amendments address the need to incorporate computer modelling and simulation to strengthen health infrastructure, including surveillance systems, contact tracing and usage of shared health data. They additionally expand the Regulation to go beyond artificial intelligence and include other necessary advances for alert and reporting systems."


bottom of page